Assembly of α-synuclein fibrils in nanoscale studied by peptide truncation and AFM

被引:18
作者
Zhang, Feng [2 ]
Lin, Xiao-Jing [1 ]
Ji, Li-Na [1 ,2 ]
Du, Hai-Ning [1 ]
Tang, Lin [2 ]
He, Jian-Hua [2 ]
Hu, Jun [2 ]
Hu, Hong-Yu [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China
基金
中国国家自然科学基金;
关键词
alpha-synuclein fibrils; morphological assembly; peptide truncation; atomic force microscopy; nanoscale;
D O I
10.1016/j.bbrc.2008.01.091
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
alpha-Synuclein (alpha-Syn) fibrils are the major component of Lewy bodies that are closely associated with the pathogenesis of Parkinson's disease, but the mechanism for the fibril assembly remains poorly understood. Here we report using a combination of peptide truncation and atomic force microscopy (AFM) to elucidate the self-assembly and morphology of the alpha-Syn fibrils. The results show that protease K significantly slims the fibrils from the mean height of similar to 6.6 to similar to 4.7 nm, whereas chaotropic denaturant urea completely breaks down the fibrils into small particles. The in situ enzymatic digestion also results in thinning of the fibrils, giving rise to some nicks on the fibrils. Moreover, N- or C-terminally truncated alpha-Syn fragments assemble into thinner filaments with the heights depending on the peptide lengths. A nine-residue peptide corresponding to the homologous GAV-motif sequence can form very thin (similar to 2.2 nm) but long (> 1 mu m) filaments. Thus, the central sequence of alpha-Syn forms a fibrillar core by cross-beta-structure that is flanked by two flexible termini, and the orientation of the fibril growth is perpendicular to the P-sheet structures. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 28 条
[1]
Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[2]
Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[3]
Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain [J].
Crowther, RA ;
Daniel, SE ;
Goedert, M .
NEUROSCIENCE LETTERS, 2000, 292 (02) :128-130
[4]
Structural organization of α-synuclein fibrils studied by site-directed spin labeling [J].
Der-Sarkissian, A ;
Jao, CC ;
Chen, J ;
Langen, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37530-37535
[5]
α-Synuclein and the Lewy body disorders [J].
Dickson, DW .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) :423-432
[6]
Ding TT, 1999, METHOD ENZYMOL, V309, P510
[7]
Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease [J].
Dominguez, DI ;
De Strooper, B .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (07) :324-330
[8]
Acceleration of α-synuclein aggregation by homologous peptides [J].
Du, Hai-Ning ;
Li, Hong-Tao ;
Zhang, Feng ;
Lin, Xiao-Jing ;
Shi, Jia-Hao ;
Shi, Yan-Hong ;
Ji, Li-Na ;
Hu, Jun ;
Lin, Dong-Hai ;
Hu, Hong-Yu .
FEBS LETTERS, 2006, 580 (15) :3657-3664
[9]
A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein [J].
Du, HN ;
Tang, L ;
Luo, XY ;
Li, HT ;
Hu, J ;
Zhou, JW ;
Hu, HY .
BIOCHEMISTRY, 2003, 42 (29) :8870-8878
[10]
Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? [J].
Goldberg, MS ;
Lansbury, PT .
NATURE CELL BIOLOGY, 2000, 2 (07) :E115-E119